In a study of 236 Ashkenazi Jewish women with breast cancer, one of three founder BRCA1/BRCA2 variants was found in 25% of early-onset breast cancer cases (diagnosed under 45 years of age) and 18.5% of women diagnosed after 45 years of age17. Here, BRCA1 is linked to breast carcinoma.